Shanghai Haoyuan Chemexpress Co., Ltd. (688131.SS)

CNY 36.76

(-0.92%)

Operating Income Summary of Shanghai Haoyuan Chemexpress Co., Ltd.

  • Shanghai Haoyuan Chemexpress Co., Ltd.'s latest annual operating income in 2023 was 128.32 Million CNY , down -47.12% from previous year.
  • Shanghai Haoyuan Chemexpress Co., Ltd.'s latest quarterly operating income in 2024 Q2 was 66.95 Million CNY , up 303.5% from previous quarter.
  • Shanghai Haoyuan Chemexpress Co., Ltd. reported an annual operating income of 271.23 Million CNY in 2022, up 29.31% from previous year.
  • Shanghai Haoyuan Chemexpress Co., Ltd. reported an annual operating income of 209.75 Million CNY in 2021, up 41.07% from previous year.
  • Shanghai Haoyuan Chemexpress Co., Ltd. reported a quarterly operating income of 79.28 Million CNY for 2024 Q3, up 18.41% from previous quarter.
  • Shanghai Haoyuan Chemexpress Co., Ltd. reported a quarterly operating income of 66.95 Million CNY for 2024 Q2, up 303.5% from previous quarter.

Annual Operating Income Chart of Shanghai Haoyuan Chemexpress Co., Ltd. (2023 - 2013)

Historical Annual Operating Income of Shanghai Haoyuan Chemexpress Co., Ltd. (2023 - 2013)

Year Operating Income Operating Income Growth
2023 128.32 Million CNY -47.12%
2022 271.23 Million CNY 29.31%
2021 209.75 Million CNY 41.07%
2020 148.68 Million CNY 76.21%
2019 84.38 Million CNY 252.14%
2018 23.96 Million CNY 48.18%
2017 16.17 Million CNY -13.96%
2016 18.79 Million CNY 128.24%
2015 8.23 Million CNY 156.01%
2014 3.21 Million CNY 57.79%
2013 2.03 Million CNY 0.0%

Peer Operating Income Comparison of Shanghai Haoyuan Chemexpress Co., Ltd.

Name Operating Income Operating Income Difference
Hubei Jumpcan Pharmaceutical Co., Ltd. 3.25 Billion CNY 96.061%
Yabao Pharmaceutical Group Co., Ltd 226.33 Million CNY 43.301%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited 5.12 Billion CNY 97.494%
Harbin Pharmaceutical Group Co., Ltd. 659.62 Million CNY 80.545%
Tasly Pharmaceutical Group Co., Ltd 1.22 Billion CNY 89.549%
Zhejiang Medicine Co., Ltd. 380.15 Million CNY 66.243%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited 1.09 Billion CNY 88.302%
Lionco Pharmaceutical Group Co.,Ltd. -148.98 Million CNY 186.138%
Humanwell Healthcare (Group) Co.,Ltd. 3.44 Billion CNY 96.277%
Ginwa Enterprise (Group) Inc. -1.69 Million CNY 7671.16%
Joincare Pharmaceutical Group Industry Co.,Ltd. 3.5 Billion CNY 96.34%
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. 22.03 Million CNY -482.288%
China Animal Husbandry Industry Co., Ltd. 402.76 Million CNY 68.138%
Jiangsu Jibeier Pharmaceutical Co., Ltd. 249.11 Million CNY 48.486%
Zhejiang Huahai Pharmaceutical Co., Ltd. 1.36 Billion CNY 90.583%
Ningbo Menovo Pharmaceutical Co., Ltd. 18.74 Million CNY -584.493%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd 1.17 Billion CNY 89.086%
Chongqing Taiji Industry(Group) Co.,Ltd 1.17 Billion CNY 89.061%
HPGC Renmintongtai Pharmaceutical Corporation 411.84 Million CNY 68.841%
Nanjing Well Pharmaceutical Group Co.,Ltd. 121.77 Million CNY -5.38%
Tianjin Tianyao Pharmaceuticals Co., Ltd. 169.4 Million CNY 24.248%
Henan Lingrui Pharmaceutical Co., Ltd. 656.3 Million CNY 80.447%
Shenzhen Chipscreen Biosciences Co., Ltd. 97.07 Million CNY -32.2%
Guizhou Yibai Pharmaceutical Co., Ltd. 145.51 Million CNY 11.809%
Jiangsu Kanion Pharmaceutical Co.,Ltd. 563.79 Million CNY 77.238%
Zhongzhu Healthcare Holding Co.,Ltd -135.23 Million CNY 194.892%
Beijing Tongrentang Co., Ltd 3.08 Billion CNY 95.839%
KPC Pharmaceuticals, Inc. 568.49 Million CNY 77.427%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. 97.08 Million CNY -32.175%
North China Pharmaceutical Company Ltd. 540.51 Million CNY 76.258%
China Resources Double-Crane Pharmaceutical Co.,Ltd. 1.51 Billion CNY 91.53%
Tibet Weixinkang Medicine Co., Ltd. 174.96 Million CNY 26.654%
China National Medicines Corporation Ltd. 2.94 Billion CNY 95.642%
Zhejiang Hisun Pharmaceutical Co., Ltd. 89.44 Million CNY -43.475%
Heilongjiang ZBD Pharmaceutical Co., Ltd. 473.24 Million CNY 72.883%
ChengDu ShengNuo Biotec Co.,Ltd. 81.1 Million CNY -58.233%
Dali Pharmaceuticalco.,Ltd -17.03 Million CNY 853.312%
Changchun BCHT Biotechnology Co. 559.29 Million CNY 77.055%
Zhejiang Shengda Bio-Pharm Co., Ltd. -45.67 Million CNY 380.954%
Shanghai Jiaoda Onlly Co.,Ltd -25.57 Million CNY 601.769%
Jiang Zhong Pharmaceutical Co.,Ltd 894.11 Million CNY 85.647%
Mayinglong Pharmaceutical Group Co., LTD. 536.62 Million CNY 76.086%
Cisen Pharmaceutical Co., Ltd. 592.57 Million CNY 78.344%
Hunan Warrant Pharmaceutical Co.,Ltd 237.11 Million CNY 45.879%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 3.3 Billion CNY 96.12%
Jianmin Pharmaceutical Group Co.,Ltd. 573.86 Million CNY 77.638%
Hunan Fangsheng Pharmaceutical Co., Ltd. 196.44 Million CNY 34.675%
Guangxi Wuzhou Zhongheng Group Co.,Ltd 132.68 Million CNY 3.284%
Guobang Pharma Ltd. 702.26 Million CNY 81.726%
Shaanxi Kanghui Pharmaceutical Co., Ltd. -61.8 Million CNY 307.643%
Kangmei Pharmaceutical Co., Ltd. 86.66 Million CNY -48.072%
Shandong Buchang Pharmaceuticals Co., Ltd. 436.01 Million CNY 70.568%
Zhejiang Starry Pharmaceutical Co.,Ltd. 138.93 Million CNY 7.634%
Henan Taloph Pharmaceutical Stock Co.,Ltd 44.16 Million CNY -190.556%
ZhuZhou QianJin Pharmaceutical Co.,Ltd 461.93 Million CNY 72.22%
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd -331.9 Million CNY 138.664%
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. 194.16 Million CNY 33.906%
Shanghai Shyndec Pharmaceutical Co., Ltd. 1.08 Billion CNY 88.136%
Shanghai Yizhong Pharmaceutical Co., Ltd. 195.45 Million CNY 34.343%
Tibet Rhodiola Pharmaceutical Holding Co. 899.09 Million CNY 85.727%
Sichuan Huiyu Pharmaceutical Co., Ltd. 124.36 Million CNY -3.184%
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. 173.9 Million CNY 26.209%
CanSino Biologics Inc. -1.93 Billion CNY 106.627%
Jiangsu Lianhuan Pharmaceutical Co., Ltd. 174.77 Million CNY 26.574%
Shandong Lukang Pharmaceutical Co.,Ltd. 277.16 Million CNY 53.7%